"Alzheimer Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Descriptor ID |
D000544
|
| MeSH Number(s) |
C10.228.140.380.100 C10.574.945.249 F03.615.400.100
|
| Concept/Terms |
Alzheimer Disease- Alzheimer Disease
- Alzheimer's Disease
- Dementia, Senile
- Senile Dementia
- Dementia, Alzheimer Type
- Alzheimer Type Dementia
- Alzheimer-Type Dementia (ATD)
- Alzheimer Type Dementia (ATD)
- Dementia, Alzheimer-Type (ATD)
- Alzheimer Type Senile Dementia
- Primary Senile Degenerative Dementia
- Dementia, Primary Senile Degenerative
- Alzheimer Sclerosis
- Sclerosis, Alzheimer
- Alzheimer Syndrome
- Alzheimer Dementia
- Alzheimer Dementias
- Dementia, Alzheimer
- Dementias, Alzheimer
- Senile Dementia, Alzheimer Type
Familial Alzheimer Disease (FAD)- Familial Alzheimer Disease (FAD)
- Alzheimer Disease, Familial (FAD)
- Alzheimer Diseases, Familial (FAD)
- Familial Alzheimer Diseases (FAD)
|
Below are MeSH descriptors whose meaning is more general than "Alzheimer Disease".
Below are MeSH descriptors whose meaning is more specific than "Alzheimer Disease".
This graph shows the total number of publications written about "Alzheimer Disease" by people in this website by year, and whether "Alzheimer Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 4 | 0 | 4 |
| 1997 | 9 | 0 | 9 |
| 1998 | 4 | 1 | 5 |
| 1999 | 10 | 0 | 10 |
| 2000 | 6 | 6 | 12 |
| 2001 | 10 | 1 | 11 |
| 2002 | 6 | 1 | 7 |
| 2003 | 8 | 5 | 13 |
| 2004 | 9 | 1 | 10 |
| 2005 | 10 | 5 | 15 |
| 2006 | 17 | 2 | 19 |
| 2007 | 12 | 2 | 14 |
| 2008 | 14 | 2 | 16 |
| 2009 | 16 | 5 | 21 |
| 2010 | 15 | 4 | 19 |
| 2011 | 23 | 5 | 28 |
| 2012 | 19 | 4 | 23 |
| 2013 | 26 | 3 | 29 |
| 2014 | 16 | 1 | 17 |
| 2015 | 11 | 8 | 19 |
| 2016 | 18 | 3 | 21 |
| 2017 | 17 | 2 | 19 |
| 2018 | 18 | 2 | 20 |
| 2019 | 21 | 3 | 24 |
| 2020 | 23 | 2 | 25 |
| 2021 | 26 | 1 | 27 |
| 2022 | 32 | 1 | 33 |
| 2023 | 31 | 3 | 34 |
| 2024 | 37 | 5 | 42 |
| 2025 | 41 | 8 | 49 |
| 2026 | 6 | 3 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Alzheimer Disease" by people in Profiles.
-
Apathy, effort-based decisions and brain integrity in Alzheimer's and Parkinson's diseases. Brain. 2026 May 05; 149(5):1635-1649.
-
2-aminobutyrate mediates the impact of air pollution on blood biomarkers of Alzheimer's disease. Alzheimers Dement. 2026 05; 22(5):e71388.
-
Systematic identification of cell-cell interactions associated with the severity of patients with Alzheimer's disease. J Alzheimers Dis. 2026 Jun; 111(3):1156-1167.
-
Target product profiles for treatments to delay or prevent symptomatic Alzheimer's disease. Nat Med. 2026 Apr; 32(4):1223-1232.
-
Harnessing viral strategies to reverse cognitive dysfunction through the integrated stress response. Science. 2026 Apr 02; 392(6793):eaea8782.
-
Modulation of Biomolecular Aggregate Morphology and Condensate Infectivity. Biomolecules. 2026 Mar 25; 16(4).
-
Systems genetic dissection of brain gene expression reveals excitotoxic mechanisms of Alzheimer's disease. Mol Psychiatry. 2026 Jun; 31(6):3462-3481.
-
Strengthening the Tripod: Upholding Autonomy Through Capacity Assessment, Surrogate Decision-Making, and Research Advanced Directives. J Law Med Ethics. 2025; 53(4):511-512.
-
Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2026 Feb; 25(2):147-159.
-
The NIH toolbox emotion battery and cerebrospinal fluid biomarkers in Alzheimer's disease: findings from the multisite ARMADA study. J Gerontol B Psychol Sci Soc Sci. 2026 01 12; 81(2).